[
    {
        "title": "Institutional owners may consider drastic measures as Adaptimmune Therapeutics plc's (NASDAQ:ADAP) recent US$18m drop adds to long-term losses - Simply Wall St",
        "description": "Institutional owners may consider drastic measures as Adaptimmune Therapeutics plc's (NASDAQ:ADAP) recent US$18m drop adds to long-term losses  Simply Wall St",
        "published date": "Wed, 11 Oct 2023 10:31:43 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMingFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1hZGFwL2FkYXB0aW1tdW5lLXRoZXJhcGV1dGljcy9uZXdzL2luc3RpdHV0aW9uYWwtb3duZXJzLW1heS1jb25zaWRlci1kcmFzdGljLW1lYXN1cmVzLWFzLWFkYXB0adIBogFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1hZGFwL2FkYXB0aW1tdW5lLXRoZXJhcGV1dGljcy9uZXdzL2luc3RpdHV0aW9uYWwtb3duZXJzLW1heS1jb25zaWRlci1kcmFzdGljLW1lYXN1cmVzLWFzLWFkYXB0aS9hbXA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://simplywall.st",
            "title": "Simply Wall St"
        }
    },
    {
        "title": "SAINT LAURENT Stock Associate Century City Bloomingdales - Kering",
        "description": "SAINT LAURENT Stock Associate Century City Bloomingdales  Kering",
        "published date": "Fri, 10 Feb 2023 08:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmtlcmluZy5jb20vZW4vdGFsZW50L2pvYi1vZmZlcnMvbm9ydGhlcm5fYW1lcmljYS9zYWludC1sYXVyZW50LXN0b2NrLWFzc29jaWF0ZS1jZW50dXJ5LWNpdHktYmxvb21pbmdkYWxlcy_SAQA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.kering.com",
            "title": "Kering"
        }
    },
    {
        "title": "Investors in Adaptimmune Therapeutics (NASDAQ:ADAP) from five years ago are still down 90%, even after 12% gain this past week - Yahoo Finance",
        "description": "Investors in Adaptimmune Therapeutics (NASDAQ:ADAP) from five years ago are still down 90%, even after 12% gain this past week  Yahoo Finance",
        "published date": "Thu, 20 Jul 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9pbnZlc3RvcnMtYWRhcHRpbW11bmUtdGhlcmFwZXV0aWNzLW5hc2RhcS1hZGFwLTExMjg1ODU5Ni5odG1s0gFkaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvaW52ZXN0b3JzLWFkYXB0aW1tdW5lLXRoZXJhcGV1dGljcy1uYXNkYXEtYWRhcC0xMTI4NTg1OTYuaHRtbA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "BioAdaptives Announces Nationwide Launch of Lung Fortress(TM) Natural Supplement - Yahoo Finance",
        "description": "BioAdaptives Announces Nationwide Launch of Lung Fortress(TM) Natural Supplement  Yahoo Finance",
        "published date": "Tue, 10 Oct 2023 12:30:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9hZGFwdGl2ZXMtYW5ub3VuY2VzLW5hdGlvbndpZGUtbGF1bmNoLWx1bmctMTIzMDAwODcxLmh0bWzSAWNodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9iaW9hZGFwdGl2ZXMtYW5ub3VuY2VzLW5hdGlvbndpZGUtbGF1bmNoLWx1bmctMTIzMDAwODcxLmh0bWw?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "Adaptimmune Therapeutics plc's (NASDAQ:ADAP) recent 12% pullback adds to one-year year losses, institutional owners may take drastic measures - Simply Wall St",
        "description": "Adaptimmune Therapeutics plc's (NASDAQ:ADAP) recent 12% pullback adds to one-year year losses, institutional owners may take drastic measures  Simply Wall St",
        "published date": "Tue, 27 Jun 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinQFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1hZGFwL2FkYXB0aW1tdW5lLXRoZXJhcGV1dGljcy9uZXdzL2FkYXB0aW1tdW5lLXRoZXJhcGV1dGljcy1wbGNzLW5hc2RhcWFkYXAtcmVjZW50LTEyLXB1bGxiYWNr0gGhAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvdXMvcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbmFzZGFxLWFkYXAvYWRhcHRpbW11bmUtdGhlcmFwZXV0aWNzL25ld3MvYWRhcHRpbW11bmUtdGhlcmFwZXV0aWNzLXBsY3MtbmFzZGFxYWRhcC1yZWNlbnQtMTItcHVsbGJhY2svYW1w?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://simplywall.st",
            "title": "Simply Wall St"
        }
    },
    {
        "title": "Adaptimmune (ADAP) to Report Q2 Earnings: What's in the Cards? - Yahoo Finance",
        "description": "Adaptimmune (ADAP) to Report Q2 Earnings: What's in the Cards?  Yahoo Finance",
        "published date": "Fri, 28 Jul 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hZGFwdGltbXVuZS1hZGFwLXJlcG9ydC1xMi1lYXJuaW5ncy0xNjMwMDA4ODcuaHRtbNIBWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2FkYXB0aW1tdW5lLWFkYXAtcmVwb3J0LXEyLWVhcm5pbmdzLTE2MzAwMDg4Ny5odG1s?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "New Forecasts: Here's What Analysts Think The Future Holds For Adaptimmune Therapeutics plc (NASDAQ:ADAP) - Simply Wall St",
        "description": "New Forecasts: Here's What Analysts Think The Future Holds For Adaptimmune Therapeutics plc (NASDAQ:ADAP)  Simply Wall St",
        "published date": "Wed, 08 Mar 2023 08:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiogFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1hZGFwL2FkYXB0aW1tdW5lLXRoZXJhcGV1dGljcy9uZXdzL25ldy1mb3JlY2FzdHMtaGVyZXMtd2hhdC1hbmFseXN0cy10aGluay10aGUtZnV0dXJlLWhvbGRzLWZvci0xOTDSAaYBaHR0cHM6Ly9zaW1wbHl3YWxsLnN0L3N0b2Nrcy91cy9waGFybWFjZXV0aWNhbHMtYmlvdGVjaC9uYXNkYXEtYWRhcC9hZGFwdGltbXVuZS10aGVyYXBldXRpY3MvbmV3cy9uZXctZm9yZWNhc3RzLWhlcmVzLXdoYXQtYW5hbHlzdHMtdGhpbmstdGhlLWZ1dHVyZS1ob2xkcy1mb3ItMTkwL2FtcA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://simplywall.st",
            "title": "Simply Wall St"
        }
    },
    {
        "title": "Why Shares of Adaptimmune Therapeutics Jumped Tuesday - The Motley Fool",
        "description": "Why Shares of Adaptimmune Therapeutics Jumped Tuesday  The Motley Fool",
        "published date": "Tue, 11 Apr 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA0LzExL3doeS1zaGFyZXMtb2YtYWRhcHRpbW11bmUtdGhlcmFwZXV0aWNzLWp1bXBlZC10dWVzL9IBAA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.fool.com",
            "title": "The Motley Fool"
        }
    },
    {
        "title": "Arcturus Therapeutics (ARCT) Surges 15.0%: Is This an Indication of Further Gains? - Yahoo Finance",
        "description": "Arcturus Therapeutics (ARCT) Surges 15.0%: Is This an Indication of Further Gains?  Yahoo Finance",
        "published date": "Sun, 16 Jul 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hcmN0dXJ1cy10aGVyYXBldXRpY3MtYXJjdC1zdXJnZXMtMTUtMDAxODAwOTc5Lmh0bWzSAVpodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9hcmN0dXJ1cy10aGVyYXBldXRpY3MtYXJjdC1zdXJnZXMtMTUtMDAxODAwOTc5Lmh0bWw?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "BioAdaptives, Inc. Celebrates Nine Years of Commercial Success in ... - GlobeNewswire",
        "description": "BioAdaptives, Inc. Celebrates Nine Years of Commercial Success in ...  GlobeNewswire",
        "published date": "Thu, 12 Oct 2023 12:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimAFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMy8xMC8xMi8yNzU5MTg0LzAvZW4vQmlvQWRhcHRpdmVzLUluYy1DZWxlYnJhdGVzLU5pbmUtWWVhcnMtb2YtQ29tbWVyY2lhbC1TdWNjZXNzLWluLUVxdWluZS1OdXRyaXRpb24uaHRtbNIBAA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.globenewswire.com",
            "title": "GlobeNewswire"
        }
    }
]